Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kromek Group plc ( (GB:KMK) ) just unveiled an update.
Kromek Group plc announced a significant increase in revenue for the first half of 2026, expecting at least £14.5 million compared to £3.7 million in the same period of 2025. This growth is attributed to strong performance in the CBRN Detection division and a major contribution from an agreement with Siemens Healthineers. The company anticipates reporting a profit before tax and positive adjusted EBITDA, marking a turnaround from the previous year’s losses, and reinforcing confidence in meeting market expectations for the full year.
The most recent analyst rating on (GB:KMK) stock is a Buy with a £8.00 price target. To see the full list of analyst forecasts on Kromek Group plc stock, see the GB:KMK Stock Forecast page.
Spark’s Take on GB:KMK Stock
According to Spark, TipRanks’ AI Analyst, GB:KMK is a Outperform.
Kromek Group plc’s overall stock score is driven by strong financial performance, particularly in revenue growth and profitability improvements. The technical analysis indicates positive momentum, although caution is advised due to the RSI nearing overbought levels. Valuation metrics suggest the stock is fairly valued, with the P/E ratio indicating reasonable pricing. The absence of earnings call and corporate events data means these factors did not influence the score.
To see Spark’s full report on GB:KMK stock, click here.
More about Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions, focusing on advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, with operations in the UK and US, Kromek provides detector components for medical, security, and industrial markets, and offers nuclear radiation detection solutions for global homeland defense and security. The company is also advancing bio-security solutions for detecting airborne pathogens.
Average Trading Volume: 2,236,842
Technical Sentiment Signal: Buy
Current Market Cap: £47.49M
For detailed information about KMK stock, go to TipRanks’ Stock Analysis page.